Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives

British Journal of Dermatology

Volumn 159, Issue 6, 2008, Pages 1267-1274

  Chawla, S ^a   Delong, M A ^b   Visscher, M O ^c   Wickett, R R ^d   Manga, P ^a   Boissy, R E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Hydroquinone; Melanin; Pigment; Skin

Indexed keywords

ARBUTIN; CATECHOL OXIDASE; DEOXYARBUTIN; DEOXYFURAN; FLUORODEOXYARBUTIN; HYDROQUINONE; MELANIN; MONOPHENOL MONOOXYGENASE; THIODEOXYARBUTIN; TYROSINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPIGMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; MELANOCYTE; MELANOGENESIS; MUSHROOM; NORMAL HUMAN; PRIORITY JOURNAL;

ARBUTIN; DOPAMINE AGENTS; ENZYME INHIBITORS; HUMANS; HYPERPIGMENTATION; MELANOCYTES; MONOPHENOL MONOOXYGENASE; TYROSINE 3-MONOOXYGENASE;

EID: 56549128584     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08864.x     Document Type: Article

References (39)

1. Sanchez-Ferrer A, Rodriguez-Lopez JN, Garcia-Canovas F et al. Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1995 1247 : 1 11.
2. Thong HY, Jee SH, Sun CC et al. The patterns of melanosome distribution in keratinocytes of human skin as one determining factor of skin colour. Br J Dermatol 2003 149 : 498 505.
3. Boissy RE. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol 2003 12 (Suppl. 2 5 12.
4. 2+. Exp Cell Res 2004 294 : 60 7.
5. Jimenez-Cervantes C, Martinez-Esparza M, Perez C et al. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J Cell Sci 2001 114 : 2335 44.
6. Winder A, Kobayashi T, Tsukamoto K et al. The tyrosinase gene family - interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 1994 40 : 613 26.
7. Ortonne JP, Nordlund JJ. Mechanisms that cause abnormal skin color. In : The Pigmentary System: Physiology and Pathophysiology (Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, eds). New York : Oxford University Press, 1998 489 502.
8. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003 16 : 101 10.
9. Kersey P, Stevenson CJ. Vitiligo and occupational exposure to hydroquinone from servicing self-photographing machines. Contact Dermatitis 1981 7 : 285 7.
10. Perez-Bernal A, Munoz-Perez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol 2000 1 : 261 8.
11. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975 111 : 40 8.
12. Zhao H, Boissy RE. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities. Am J Med Sci 1994 308 : 322 30.
13. Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol 2005 14 : 601 8.
14. Pomerantz SH. The tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem 1966 241 : 161 8.
15. Hamed SH, Sriwiriyanont P, deLong MA et al. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. J Cosmet Sci 2006 57 : 291 308.
16. Segel LH. Enzyme Kinetics. New York : Wiley, 1975 377 81.
17. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996 276 : 765 9.
18. Balkrishnan R. Predictors of health-related quality of life in women with melasma. Cosmet Dermatol 2003 16 : 25 30.
19. Balkrishnan R, Kelly AP, McMichael A et al. Improved quality of life with effective treatment of facial melasma: the pigment trial. J Drugs Dermatol 2004 3 : 377 81.
20. Watabe H, Soma Y, Ito M et al. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor. J Invest Dermatol 2002 118 : 35 42.
21. Krueger RC. The inhibition of tyrosinase. Arch Biochem 1955 57 : 52 60.
22. Healey DF, Strothkamp KG. Inhibition of the catecholase and cresolase activity of mushroom tyrosinase by azide. Arch Biochem Biophys 1981 211 : 86 91.
23. Khatib S, Nerya O, Musa R et al. Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem 2005 13 : 433 41.
24. Passi S, Nazzaro-Porro M. Molecular basis of substrate and inhibitory specificity of tyrosinase: phenolic compounds. Br J Dermatol 1981 104 : 659 65.
25. Kvalnes KL, deLong MA, Bradbury BJ et al. Discovery of a Novel Skin Lightening Active, deoxyArbutin, using a Structure-Activity Relationship Approach. Cincinnati, OH : Procter & Gamble, Research and Development Department Report, Cosmetic and Fragrances Technology Division, 1994.
26. Shimizu K, Kondo R, Sakai K. Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations. Planta Med 2000 66 : 11 15.
27. Tanford C. The Hydrophobic Effect: Formation of Micelles and Biological Membranes, 2nd edn. New York : John Wiley & Sons, 1980.
28. Wilcox DE, Gorras AG, Hwang YT et al. Substrate analog binding to the coupled binuclear copper active site in tyrosinase. J Am Chem Soc 1985 107 : 4015 27.
29. Decker H, Dillinger R, Tuczek F. How does tyrosinase work? Recent insights from model chemistry and structural biology. Angew Chem Int Ed Engl 2000 39 : 1591 5.
30. Curto EV, Kwong C, Hermersdörfer H et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol 1999 57 : 663 72.
31. Smith CJ, O'Hare KB, Allen JC. Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res 1988 1 : 386 9.
32. Halaban R, Pomerantz SH, Marshall S et al. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 1983 97 : 480 8.
33. Nerya O, Vaya J, Musa R et al. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem 2003 51 : 1201 7.
34. Fenoll LG, Rodriguez-Lopez JN, Garcia-Sevilla F et al. Oxidation by mushroom tyrosinase of monophenols generating slightly unstable o-quinones. Eur J Biochem 2000 267 : 5865 78.
35. Yong G, Leone C, Strothkamp KG. Agaricus bisporus metapotyrosinase: preparation, characterization, and conversion to mixed-metal derivatives of the binuclear site. Biochemistry 1990 29 : 9684 90.
36. Kobayashi N, Nakagawa A, Muramatsu T et al. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 1998 110 : 806 10.
37. Mani I, Sharma V, Tamboli I et al. Interaction of melanin with proteins - the importance of an acidic intramelanosomal pH. Pigment Cell Res 2001 14 : 170 9.
38. Hamed SH, Sriwiiyanont P, Wickett RR et al. Effect of deoxyarbutin on melanogenesis: in vivo comparison with other melanogenesis inhibitor. J Cosmet Sci 2004 55 : 118 19.
39. Chen QX, Kubo I. Kinetics of mushroom tyrosinase inhibition by quercetin. J Agric Food Chem 2002 50 : 4108 12.